2022 – Satellos

SATELLOS Announces Development Candidate

- SAT-3153 Designated for pre-IND Studies - TORONTO, January 03, 2023 – Satellos Bioscience Inc.

Jessica Richmond2023-01-02T22:37:06+00:00January 3rd, 2023|2022, Press Releases|

SATELLOS BIOSCIENCE ANNOUNCES Q3 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS TORONTO, November 23, 2022 –

Jessica Richmond2022-11-23T23:39:17+00:00November 23rd, 2022|2022, Press Releases|

-Proof of concept studies to be completed by YE- TORONTO, November 03, 2022 – Satellos

Jessica Richmond2022-11-04T02:46:15+00:00November 3rd, 2022|2022, Press Releases|

Satellos Bioscience Inc. to present preliminary preclinical proof of concept data for an additional rare

Jessica Richmond2022-10-11T21:48:48+00:00October 11th, 2022|2022, Press Releases|

TORONTO, October 6, 2022 – Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Corporation”), is

Jessica Richmond2022-10-06T21:53:11+00:00October 6th, 2022|2022, Press Releases, Uncategorized|

SATELLOS BIOSCIENCE ANNOUNCES OTCQB LISTING IN THE UNITED STATES TORONTO, October 6, 2022 – Satellos

Jessica Richmond2022-10-11T21:37:12+00:00October 6th, 2022|2022, Press Releases, Uncategorized|

Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer

Jessica Richmond2022-09-28T14:49:52+00:00September 28th, 2022|2022, Press Releases|

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS

Jessica Richmond2022-09-13T14:28:03+00:00September 13th, 2022|2022, Press Releases|

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS

Jessica Richmond2022-09-09T12:55:32+00:00September 7th, 2022|2022, Press Releases, Uncategorized|

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS

Jessica Richmond2022-08-31T14:16:34+00:00August 31st, 2022|2022, Press Releases|